In the lab and in the clinic, alisertib with TAK-228 excels against solid tumors, including triple-negative breast cancer
Title: In the lab and in the clinic, alisertib with TAK-228 excels against solid tumors, including triple-negative breast cancer Article Link

    Page 1 of 1

  • 1